References
- Aaron, E., C. Blum, D. Seidman, M. Hoyt, J. Simone, M. Sullivan, and D. K. Smith. 2018. “Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States.” AIDS Patient Care and STDs 32 (1):16–23. doi:https://doi.org/10.1089/apc.2017.0201
- Adams, L. M., B. Balderson, K. Brown, S. Bush, and B. J. Packett. 2018. “Who Starts the Conversation and Who Receives Preexposure Prophylaxis (PrEP)? A Brief Online Survey of Medical Providers' PrEP Practices.” Health Education & Behavior 45 (5):723–729. doi:https://doi.org/10.1177/1090198117752789
- Auerbach, J. D., S. Kinsky, G. Brown, and V. Charles. 2015. “Knowledge, Attitudes, and Likelihood of Pre-exposure Prophylaxis (PrEP) Use Among US Women at Risk of Acquiring HIV.” AIDS Patient Care and STDs 29 (2):102–110. doi:https://doi.org/10.1089/apc.2014.0142
- Bradley, E., K. Forsberg, J. E. Betts, J. B. DeLuca, E. Kamitani, S. E. Porter, T. A. Sipe, and K. Hoover. 2019. “Factors Affecting Pre-exposure Prophylaxis Implementation for Women in the United States: A Systematic Review.” Journal of Women's Health (2002) 28 (9):1272–1285. doi:https://doi.org/10.1089/jwh.2018.7353
- Brawner, B. M., M. S. Sommers, K. Moore, R. Aka-James, T. Zink, K. M. Brown, and J. D. Fargo. 2016. “Exploring Genitoanal Injury and HIV Risk Among Women: Menstrual Phase, Hormonal Birth Control, and Injury Frequency and Prevalence.” Journal of Acquired Immune Deficiency Syndromes 71 (2):207–212. doi:https://doi.org/10.1097/QAI.0000000000000824
- Calabrese, S. K., J. F. Dovidio, M. Tekeste, T. Taggart, R. W. Galvao, C. B. Safon, T. C. Willie, A. Caldwell, C. Kaplan, and T. S. Kershaw. 2018. “HIV Pre-exposure Prophylaxis Stigma as a Multidimensional Barrier to Uptake among Women Who attend Planned Parenthood.” Journal of Acquired Immune Deficiency Syndromes 79 (1):46–53. doi:https://doi.org/10.1097/QAI.0000000000001762
- Center for Disease Control and Prevention (CDC). 2018. “Pre-exposure Prophylaxis for the Prevention of HIV Infection in the United States-2017 Update: Clinical Providers' Supplement.” Accessed on September 18, 2020. www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-provider-supplement-2017.pdf
- Centers for Disease Control and Prevention (CDC). 2020. “HIV Surveillance Report, 2018 (Updated) (Vol. 31).” Accessed on August 7, 2020. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
- Charmaz, K. 2014. Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis. London: SAGE.
- Chittamuru, D., V. Frye, B. A. Koblin, B. Brawner, H. V. Tieu, A. Davis, and A. M. Teitelman. 2020. “PrEP Stigma, HIV Stigma, and Intention to Use PrEP Among Women in New York City and Philadelphia.” Stigma and Health 5 (2):240–246. doi:https://doi.org/10.1037/sah0000194
- Collier, K. L., L. G. Colarossi, and K. Sanders. 2017. “Raising Awareness of Pre-Exposure Prophylaxis (PrEP) Among Women in New York City: Community and Provider Perspectives.” Journal of Health Communication 22 (3):183–189. doi:https://doi.org/10.1080/10810730.2016.1261969
- Darlington, C. K., and S. P. Hutson. 2017. “Understanding HIV-Related Stigma Among Women in the Southern United States: A Literature Review.” AIDS & Behavior 21 (1):12–26. doi:https://doi.org/10.1007/s10461-016-1504-9
- Farmer, E. K., D. E. Koren, A. Cha, K. Grossman, and D. W. Cates. 2019. “The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis.” AIDS Patient Care and STDs 33 (5):207–213. doi:https://doi.org/10.1089/apc.2018.0294
- Glick, J. L., R. Russo, B. Jivapong, L. Rosman, D. Pelaez, K. H. Footer, and S. G. Sherman. 2019. “The PrEP Care Continuum Among Cisgender Women Who Sell Sex and/or Use Drugs Globally: A Systematic Review.” AIDS & Behavior 24 (5): 1312–1333.
- Golub, S. A. 2018. “PrEP Stigma: Implicit and Explicit Drivers of Disparity.” Current HIV/AIDS Reports 15 (2):190–197. doi:https://doi.org/10.1007/s11904-018-0385-0
- Goparaju, L., N. C. Praschan, L. Warren-Jeanpiere, L. S. Experton, M. A. Young, and S. Kassaye. 2017. “Stigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake Among US Women.” Journal of AIDS & Clinical Research 8 (9):730.
- Hirschhorn, L. R., R. N. Brown, E. E. Friedman, G. J. Greene, A. Bender, C. Christeller, A. Bouris, et al. 2020. “Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago.” Journal of Acquired Immune Deficiency Syndromes 84 (5):497–507. doi:https://doi.org/10.1097/QAI.0000000000002377
- Hodges-Mameletzis, I., V. A. Fonner, S. Dalal, N. Mugo, B. Msimanga-Radebe, and R. Baggaley. 2019. “Pre-exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions.” Drugs 79 (12):1263–1276. doi:https://doi.org/10.1007/s40265-019-01143-8
- Johnson, A. K., F. E. Fletcher, E. Ott, M. Wishart, E. E. Friedman, J. Terlikowski, and S. Haider. 2020. “Awareness and Intent to Use Pre-exposure Prophylaxis (PrEP) Among African American Women in a Family Planning Clinic.” Journal of Racial and Ethnic Health Disparities 7 (3):550–554. doi:https://doi.org/10.1007/s40615-019-00683-9
- Nowell, L. S., J. M. Norris, D. E. White, and N. J. Moules. 2017. “Thematic Analysis: Striving to Meet the Trustworthiness Criteria.” International Journal of Qualitative Methods 16 (1):1–13. doi:https://doi.org/10.1177/1609406917733847
- Nydegger, L. A., J. Dickson-Gomez, and T. Ko Ko. 2020. “Structural and Syndemic Barriers to PrEP Adoption Among Black Women at High Risk for HIV: A Qualitative Exploration.” Culture, Health & Sexuality. Advance online publication. doi:https://doi.org/10.1080/13691058.2020.1720297
- Qin, Y., C. Price, R. Rutledge, L. Puglisi, L. M. Madden, and J. P. Meyer. 2020. “Women's Decision-making About PrEP for HIV Prevention in Drug Treatment Contexts.” Journal of the International Association of Providers of AIDS Care 19:1–11.
- Sales, J. M., A. L. Phillips, I. Tamler, T. Munoz, C. Cwiak, and A. N. Sheth. 2019. “Patient Recommendations for PrEP Information Dissemination at Family Planning Clinics in Atlanta, Georgia.” Contraception 99 (4):233–238. doi:https://doi.org/10.1016/j.contraception.2018.12.008
- Seidman, D., K. Carlson, S. Weber, J. Witt, and P. J. Kelly. 2016. “United States Family Planning Providers' Knowledge of and Attitudes Towards Preexposure Prophylaxis for HIV Prevention: A National Survey.” Contraception 93 (5):463–469. doi:https://doi.org/10.1016/j.contraception.2015.12.018
- Sheth, A. N., C. P. Rolle, and M. Gandhi. 2016. “HIV Pre-exposure Prophylaxis for Women.” Journal of Virus Eradication 2 (3):149–155. doi:https://doi.org/10.1016/S2055-6640(20)30458-1
- Tekeste, M., S. Hull, J. F. Dovidio, C. B. Safon, O. Blackstock, T. Taggart, T. S. Kershaw, et al. 2019. “Differences in Medical Mistrust Between Black and White Women: Implications for Patient-Provider Communication About PrEP.” AIDS & Behavior 23 (7):1737–1748. doi:https://doi.org/10.1007/s10461-018-2283-2
- Turner, L., A. Roepke, E. Wardell, and A. M. Teitelman. 2018. “Do You PrEP? A Review of Primary Care Provider Knowledge of PrEP and Attitudes on Prescribing PrEP.” The Journal of the Association of Nurses in AIDS Care: JANAC 29 (1):83–92. doi:https://doi.org/10.1016/j.jana.2017.11.002
- Wilson, K., J. Bleasdale, and S. M. Przybyla. 2020. “Provider-Patient Communication on Pre-Exposure Prophylaxis (Prep) for HIV Prevention: An Exploration of Healthcare Provider Challenges.” Health Communication. Advance online publication. doi:https://doi.org/10.1080/10410236.2020.1787927
- Zraick, K., and S. E. Garcia. 2019. “California Makes H.I.V.-Prevention Drugs Available Without a Prescription.” New York Times, October 9. Accessed on September 18, 2020. https://www.nytimes.com/2019/10/09/us/california-hiv-drugs-prep.html